findmyKOL
Clinical trialNCT03726489CompletedInterventional

Light Treatment Effectiveness (LITE) Study

SponsorUniversity of PennsylvaniaEnrollment783PsoriasisPsoriatic Plaque
View the registry record on ClinicalTrials.gov

Summary

The lay summary the sponsor registered on ClinicalTrials.gov.

To compare the effectiveness, safety (tolerability), and duration of treatment response at 12 weeks of home versus office-based narrowband ultraviolet B phototherapy for the treatment of psoriasis

Investigators

The overall officials registered on this study. Names that resolve to a findmyKOL profile link to it; the rest are shown as registered.

A profile link is shown only when the registered name resolves to a person record with a confident, namesake-checked match; ambiguous names stay unlinked.

Sites

38 registered facilities, with the per-site recruitment status where the registry publishes one. ClinicalTrials.gov does not publish per-site enrollment counts.

United States
  • Total Skin & Beauty Dermatology Center

    Birmingham, Alabama, United States

  • Mayo Clinic Arizona

    Scottsdale, Arizona, United States

  • Johnson Dermatology

    Fort Smith, Arkansas, United States

  • University of Southern California

    Los Angeles, California, United States

  • University of California, San Francisco

    San Francisco, California, United States

  • George Washington University

    Washington D.C., District of Columbia, United States

  • Howard University

    Washington D.C., District of Columbia, United States

  • Northwestern University

    Chicago, Illinois, United States

  • Dawes Fretzin Clinical Research

    Indianapolis, Indiana, United States

  • Md Claiborne and Associates, Llc

    New Orleans, Louisiana, United States

  • Mainehealth/maine Medical Center

    Portland, Maine, United States

  • Johns Hopkins University

    Baltimore, Maryland, United States

  • Dermassociates Llc

    Silver Spring, Maryland, United States

  • Brigham and Women'S Hospital

    Boston, Massachusetts, United States

  • Dermatology Specialist of Brighton

    Brighton, Michigan, United States

  • Henry Ford Health System

    Detroit, Michigan, United States

  • Washington University in St. Louis

    St Louis, Missouri, United States

  • Psoriasis Treatment Center of Central New Jersey

    East Windsor, New Jersey, United States

  • Heymann, Manders, Green, and Sommer, Llc

    Marlton, New Jersey, United States

  • University of New Mexico

    Albuquerque, New Mexico, United States

  • Hhc Kings County Hospital

    Brooklyn, New York, United States

  • Suny Downstate Health Sciences University

    Brooklyn, New York, United States

  • Buffalo Medical Group

    Buffalo, New York, United States

  • Infinity Dermatology Nyc

    Queens, New York, United States

  • Montefiore Medical Center

    The Bronx, New York, United States

  • Wake Forest University Health Sciences

    Winston-Salem, North Carolina, United States

  • Ohio State University

    Columbus, Ohio, United States

  • Pennsyvlania Centre for Dermatology

    Exton, Pennsylvania, United States

  • Temple University

    Philadelphia, Pennsylvania, United States

  • University of Pennsylvania

    Philadelphia, Pennsylvania, United States

  • Dermatology Treatment and Research Center

    Dallas, Texas, United States

  • Menter Dermatology Research Institute

    Dallas, Texas, United States

  • West Houston Dermatology

    Houston, Texas, United States

  • University of Utah

    Salt Lake City, Utah, United States

  • University of Vermont & State Agriculture College

    Burlington, Vermont, United States

  • University of Virginia

    Charlottesville, Virginia, United States

  • Frontier Derm Partners Cro, Llc

    Mill Creek, Washington, United States

  • University of Wisconsin

    Madison, Wisconsin, United States

Site investigator names are published by ClinicalTrials.gov only while a study recruits, so completed studies list sites without them.

Drugs studied

No drug or biological interventions are in our data for this study. It may test a procedure, device or behavioral intervention, or the intervention list isn't in our current snapshot. See the registry record ↗. Why? →

Registration & key dates

Registry attributes as recorded on the ClinicalTrials.gov study record.

Start
1 Mar 2019
Primary completion
31 Oct 2023
Completion
30 Dec 2023
Last update posted
19 Sept 2024
Registered enrollment
783
Registry id
NCT03726489

Source: ClinicalTrials.gov, via the CTTI AACT database, data as of 24 Aug 2026. Registry facts are shown as registered by the study sponsor; findmyKOL does not interpret them.